- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03522896
Effect of Orange Juice on Glycemic Response
June 27, 2018 updated by: Gary Williamson, University of Leeds
Effect of Hesperidin in Orange Juice on Glycemic Response in Healthy Volunteers
Orange juice naturally contains high concentrations of hesperidin, which affects glucose absorption in in vitro experiments.
This study is to test if hesperidin and other components of orange juice (not other sugars or organic acids) affect the post-prandial blood glucose concentration derived from sugars already present in the orange juice.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Healthy volunteers will consume orange juice with added water or food-grade hesperidin.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leeds, United Kingdom, LS29JT
- University of Leeds
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- fasting blood glucose below 5.9 mM
Exclusion Criteria:
- fasting glucose above 6 mM pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: control meal
glucose, fructose, sucrose, malic acid and citric acid in water
|
balancing sugars and organic acids
|
|
Experimental: test meal 1
orange juice with added hesperidin (low dose)
|
orange juice plus hesperidin low dose
|
|
Experimental: test meal 2
orange juice with added hesperidin (high dose)
|
orange juice plus hesperidin higher dose
|
|
Experimental: test meal 3
diluted orange juice with added hesperidin
|
diluted orange juice plus hesperidin low dose
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood glucose concentration
Time Frame: 3 hours
|
iAUC/[glucose]max
|
3 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 30, 2017
Primary Completion (Actual)
June 27, 2018
Study Completion (Actual)
June 27, 2018
Study Registration Dates
First Submitted
April 30, 2018
First Submitted That Met QC Criteria
May 10, 2018
First Posted (Actual)
May 11, 2018
Study Record Updates
Last Update Posted (Actual)
June 28, 2018
Last Update Submitted That Met QC Criteria
June 27, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MEEC15-044b
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.